Winia Dimchae Ultra-Low Temperature Vaccine Freezer, Awaiting MFDS Certification Process

Medibox Developed in January Completes Standard Certification

Ultra-low Temperature Freezer for Vaccine Storage
[Photo by Winia Dimchae]

[Asia Economy Reporter Kim Heung-soon] Winia Dimchae has entered the final stage of launching an ultra-low temperature freezer developed for the transportation and storage of COVID-19 vaccines.

On the 18th, Winia Dimchae announced that it has completed the certification for vaccine storage freezers for the ultra-low temperature freezer "MediBox" and only the certification process from the Ministry of Food and Drug Safety remains.

Winia Dimchae developed the MediBox in January and filed for trademark registration and related technology patents. This product can maintain an ultra-low temperature state for a certain period (3-4 hours) during distribution and storage using a separate battery pack. With a capacity of 90ℓ and a weight of 65kg, the compact freezer maximizes space utilization to store vaccines for 18,000 people per unit.

Additionally, the company explained that the temperature can be set from minus 80 degrees Celsius to plus 10 degrees Celsius, allowing customized storage for all vaccines scheduled for domestic inoculation, including the UK Pfizer and US Moderna vaccines that require ultra-low temperature transport and storage, as well as those stored at room temperature.

A Winia Dimchae official said, "We will do our best to launch the ultra-low temperature freezer that can distribute COVID-19 vaccines more safely and quickly, contributing to overcoming COVID-19 as a company responsible for the health and safety of the public."

This content was produced with the assistance of AI translation services.